Abstract
GABAA receptor activation augments electrically-stimulated release of norepinephrine (NE) from rat brain slices. Because this effect is not observed in synaptoneurosomes, GABA probably acts on inhibitory interneurons to disinhibit NE release. To determine whether opioids or adenosine influence GABA-augmented NE release, hypothalamic and cortical slices from female rats were superfused with GABA or vehicle in the presence and absence of 10 μM morphine or 100 μM adenosine. GABA augments [3H]NE release in the cortex and hypothalamus. Morphine alone has no effect on [3H]NE release, but attenuates GABA augmentation of [3H]NE release in both brain regions. Adenosine alone modestly inhibits [3H]NE release in the cortex, but not in the hypothalamus. Adenosine inhibits GABA-augmented [3H]NE release in both brain regions. The general protein kinase inhibitor H-7, augments [3H]NE release in both brain regions and may have additive effects with GABA in cortical slices. These results implicate opioid and adenosine interneurons and possibly protein kinases in regulating GABAergic influences on NE transmission.
Similar content being viewed by others
REFERENCES
Dennis, T., Curet, O., Nishikawa, T., and Scatton, B. 1985. Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission. Naunyn Schmiedebergs Arch. Pharmacol. 331:225–234.
Scatton, B., Lloyd, K. G., Zivkovic, B., Dennis, T., Claustre, Y., Dedek, J., Arbilla, S., Langer, S. Z., and Bartholini, G. 1987. Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat. J. Pharmacol. Exp. Ther. 241:251–257.
Fuchs, E., Mansky, T., Stock, K. W., Vijayan, E., and Wuttke, W. 1984. Involvement of catecholamines and glutamate in GABAergic mechanism regulatory to luteinizing hormone and prolactin secretion. Neuroendocrinol. 38:484–489.
Adler, B. A. and Crowley, W. R. 1986. Evidence for gammaaminobutyric acid modulation of ovarian hormonal effects on luteinizing hormone secretion and hypothalamic catecholamine activity in the female rat. Endocrinol. 118:91–97.
Hartman, R. D., He, J. R., and Barraclough, C. A. 1990. Gamma-aminobutyric acid-A and-B receptor antagonists increase luteinizing hormone-releasing hormone neuronal responsiveness to intracerebroventricular norepinephrine in ovariectomized estrogen-treated rats. Endocrinol. 127:1336–1345.
Suzdak, P. D. and Gianutsos, G. 1985. Differential coupling of GABA-A and GABA-B receptors to the noradrenergic system. J. Neural Transm. 62:77–89.
Gervais, R. 1987. Local GABAergic modulation of noradrenaline release in the rat olfactory bulb measured on superfused slices. Brain Res. 400:151–154.
Navarro, C. E., Cabrera, R. J., and Donoso, A. O. 1995. Interaction between glutamate and GABA on 3H-noradrenaline release from rat hypothalamus. Brain Res. Bull. 37:119–122.
Taniyama, K., Niwa, M., Kataoka, Y., and Yamashita, K. 1992. Activation of protein kinase C suppresses the gamma-aminobutyric acidB receptor-mediated inhibition of the vesicular release of noradrenaline and acetylcholine. J. Neurochem. 58:1239–1245.
Bonanno, G. and Raiteri, M. 1987. Release-regulating GABAA receptors are present on noradrenergic nerve terminals in selective areas of the rat brain. Synapse 1:254–257.
Peoples, R. W., Giridhar, J., and Isom, G. E. 1991. Gammaaminobutyric acid enhancement of potassium-stimulated release of [3H]norepinephrine by multiple mechanisms in rat cortical slices. Biochem. Pharmacol. 41:119–123.
Gonzalez, M. P., Oset-Gasque, M. J., Castro, E., Bugeda, J., Arce, C., and Parramon, M. 1992. Mechanism through which GABAA receptor modulates catecholamine secretion from bovine chromaffin cells. Neurosci. 47:487–494.
Hu, P. S., Jin, S., and Fredholm, B. B. 1992. Glycine and GABA potentiate 4-aminopyridine and/or N-methyl-D-aspartate induced [3H]-noradrenaline release from rat hippocampal slices. Acta Physiol. Scand. 145:77–78.
Fiber, J. M. and Etgen, A. M. 1997. GABA augments basal and electrically stimulated 3H-norepinephrine release in hypothalamic, preoptic area and cortical slices of female rats. Neurochem. Int. 31:769–780.
Fiber, J. M. and Etgen, A. M. 1998. Evidence that GABA augmentation of norepinephrine release is mediated by interneurons. Brain Res. 790:329–333.
Hagan, R. M. and Hughes, I. E. 1984. Opioid receptor sub-types involved in the control of transmitter release in cortex of the brain of the rat. Neuropharmacol. 23:491–495.
Werling, L. L., Brown, S. R., and Cox, B. M. 1987. Opioid receptor regulation of the release of norepinephrine in brain. Neuropharmacol. 26:987–996.
Peoples, R. W., Giridhar, J., and Isom, G. E. 1991. Gammaaminobutyric acidA (GABAA) receptor modulation of morphine inhibition of norepinephrine release. Biochem. Pharmacol. 42 Suppl:121–126.
Ebstein, R. P. and Daly, J. W. 1982. Release of norepinephrine and dopamine from brain vesicular preparations: effects of adenosine analogues. Cell. Mol. Neurobiol. 2:193–204.
Allgaier, C., Greber, R., and Hertting, G. 1991. Studies on the interaction between presynaptic alpha 2-adrenoceptors and adenosine A1 receptors located on noradrenergic nerve terminals. Naunyn Schmiedebergs Arch. Pharmacol. 344:187–192.
von Kugelgen, I., Spath, L., and Starke, K. 1992. Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors. Naunyn Schmiedebergs Arch. Pharmacol. 346:187–196.
von Kugelgen, I., Spath, L., and Starke, K. 1994. Evidence for P2-purinoceptor-mediated inhibition of noradrenaline release in rat brain cortex. Br. J. Pharmacol. 113:815–822.
Koch, H., Kugelgen, I., and Starke, K. 1997. P2-receptor-mediated inhibition of noradrenaline release in the rat hippocampus. Naunyn Schmiedebergs Arch. Pharmacol. 355:707–715.
Daschmann, B., Allgaier, C., Nakov, R., and Hertting, G. 1988. Staurosporine counteracts the phorbol ester-induced enhancement of neurotransmitter release in hippocampus. Arch. Int. Pharmacodyn. Ther. 296:232–245.
Dekker, L. V., De Graan, P. N., Pijnappel, P., Oestreicher, A. B., and Gispen, W. H. 1991. Noradrenaline release from streptolysin O-permeated rat cortical synaptosomes: effects of calcium, phorbol esters, protein kinase inhibitors, and antibodies to the neuron-specific protein kinase C substrate B-50 (GAP-43). J. Neurochem. 56:1146–1153.
Wang, H. Y. and Friedman, E. 1987. Protein kinase C: regulation of serotonin release from rat brain cortical slices. Eur. J. Pharmacol. 141:15–21.
Tsuda, K. and Masuyama, Y. 1990. The role of protein kinase C and calcium in the regulation of norepinephrine release from the vascular adrenergic neurons in hypertension. Am. J. Hypertens. 3:879–882.
Gillette, M. A. and Dacheux, R. F. 1996. Protein kinase modulation of GABAA currents in rabbit retinal rod bipolar cells. J. Neurophysiol. 76:3070–3086.
Hu, H. Z. and Li, Z. W. 1997. Modulation of nicotinic ACh-, GABAA-and 5-HT3-receptor functions by external H-7, a protein kinase inhibitor, in rat sensory neurones. Br. J. Pharmacol. 122:1195–1201.
Beckman, M. L., Bernstein, E. M., and Quick, M. W. 1998. Protein kinase C regulates the interaction between a GABA transporter and syntaxin 1A. J. Neurosci. 18:6103–6112.
Stevens, C. F. and Sullivan, J. M. 1998. Regulation of the readily releasable vesicle pool by protein kinase C. Neuron 21:885–893.
Fiber, J. M. and Etgen, A. M. 1998. GABA-augmented 3H-norepinephrine release is modulated by opioids in brain slices from female rats. Soc. Neurosci. Abstr. 24:824.16.
Yamamoto, C. 1972. Activation of hippocampal neurons by mossy fiber stimulation in thin brain sections in vitro. Exp. Brain Res. 14:423–435.
Karkanias, G. B. and Etgen, A. M. 1993. Estradiol attenuates α2-adrenoceptor-mediated inhibition of hypothalamic norepinephrine release. J. Neurosci. 13:3448–3455.
Petitti, N. and Etgen, A. M. 1989. Progesterone depression of norepinephrine-stimulated cAMP accumulation in hypothalamic slices. Brain Res. Mol. Brain Res. 5:109–119.
Diez-Guerra, F. J., Augood, S., Emson, P. C., and Dyer, R. G. 1987. Opioid peptides inhibit the release of noradrenaline from slices of rat medial preoptic area. Exp. Brain Res. 66:378–384.
Bonanno, G. and Raiteri, M. 1987. A carrier for GABA uptake exists on noradrenaline nerve endings in selective rat brain areas but not on serotonin terminals. J. Neural Transm. 69:59–70.
Przewlocka, B., Lason, W., and Dziedzicka, M. 1990. Modulation of prodynorphin peptides release from the rat spinal cord in vitro. Neuropeptides 16:201–206.
Mulder, A. H., Hogenboom, F., Wardeh, G., and Schoffelmeer, A. N. 1987. Morphine and enkephalins potently inhibit [3H]noradrenaline release from rat brain cortex synaptosomes: further evidence for a presynaptic localization of mu-opioid receptors. J. Neurochem. 48:1043–1047.
Trendelenburg, A. U., Cox, S. L., Schelb, V., Klebroff, W., Khairallah, L., and Starke, K. 2000. Modulation of (3)H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and β-adrenoceptors in mouse tissues. Br. J. Pharmacol. 130:321–330.
Vathy, I. and Etgen, A. M. 1996. Effects of prenatal morphine and adult estrogen administration on μ-opioid inhibition of norepinephrine release from hypothalamic slices. Neuroendocrinol. 63:61–68.
Leahy, J. C. and Vallano, M. L. 1991. Differential effects of isoquinolinesulfonamide protein kinase inhibitors on CA1 responses in hippocampal slices. Neurosci. 44:361–370.
Corradetti, R., Pugliese, A. M., and Ropert, N. 1989. The protein kinase C inhibitor 1-(5-isoquinolinesulphonyl)-2-methylpiperazine (H-7) disinhibits CA1 pyramidal cells in rat hippocampal slices. Br. J. Pharmacol. 98:1376–1382.
Majewski, H., Kotsonis, P., Iannazzo, L., Murphy, T. V., and Musgrave, I. F. 1997. Protein kinase C and transmitter release. Clin. Exp. Pharmacol. Physiol. 24:619–623.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fiber, J.M., Etgen, A.M. Modulation of GABA-Augmented Norepinephrine Release in Female Rat Brain Slices by Opioids and Adenosine. Neurochem Res 26, 853–858 (2001). https://doi.org/10.1023/A:1011676505575
Issue Date:
DOI: https://doi.org/10.1023/A:1011676505575